FDA NDC Directory · JSON-LD · Markdown

CHOLESTYRAMINE

NDC 24658-266 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Generic namecholestyramine
Labeler / ManufacturerPURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Marketing categoryAbbreviated NDA (generic) · App ANDA074557
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCHOLESTYRAMINE (4 g/9g)
Marketing started20230314
Package count3

External sources

Source: openFDA. Public-domain (CC0).